Cigna Group stock: November 5, 2026 earnings are scheduled for Cigna Group stock

Published on 10/20/2026 at 16:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cigna posted USD 71.67 billion revenue in Q2 2026. Cigna Group stock costs EUR 270.80 on October 20, 2026, up 1.63 percent versus the Xetra close.

Revenue and valuation

The Cigna Group scheduled third-quarter results for November 5, 2026.
Cigna reported USD 71.67 billion revenue in the second quarter of 2026.
Cigna Group stock costs EUR 270.80 at Lang & Schwarz on October 20, 2026 at 4:31 p.m. CEST, 1.63 percent above the Xetra close of October 19, 2026.
Cigna had a USD 80.7 billion market capitalization and a P/E ratio of 12.62 as of October 20, 2026.

Extreme Nahaufnahme eines Stethoskop-Bruststücks auf einem medizinischen Formular mit Bokeh-Hintergrund — Cigna Group Makroaufnahme eines Stethoskops auf medizinischem Formular, ISIN US1255231003, Chrome-Metalloberfläche mit Bokeh-Hintergrund, Illustration mit AI erstellt.

Cigna Group (ISIN US1255231003) has scheduled its third-quarter 2026 earnings release for November 5, 2026. PR Newswire reported that the company will publish its results by 6:30 a.m. ET and hold its earnings call at 8:30 a.m. ET. Cigna Group stock was trading at EUR 270.80 at Lang & Schwarz on October 20, 2026 at 4:31 p.m. CEST, up 1.63 percent versus the Xetra close of October 19, 2026 at EUR 266.45.

USD 71.67 billion revenue in the second quarter

The latest reported quarter gives investors a clear operating reference before the November report. Cigna posted total revenue of USD 71.67 billion in the second quarter of 2026, while net income attributable to common shareholders reached USD 1.66 billion and GAAP diluted earnings per share came to USD 6.29, according to Yahoo Finance on July 30, 2026. Management also raised full-year adjusted earnings per share guidance to at least USD 30.45.

USD 239.51 to USD 311.34 range

Cigna's NYSE-listed shares had a 52-week range of USD 239.51 to USD 311.34 as of October 20, 2026. The US quote stood at USD 305.31 at 10:33 a.m. ET, leaving it 1.94 percent below the 52-week high, while volume was 199,270 shares. The German euro quotation therefore sits in a separate currency frame from the US listing.

USD 80.7 billion market value

Cigna had a market capitalization of USD 80.7 billion and a P/E ratio of 12.62 as of October 20, 2026. On October 2, 2026, Piper Sandler analyst Jessica Tassan raised the price target from USD 346.00 to USD 370.00 and maintained an Overweight rating, as Markets Insider reported. The USD 370.00 target was 21.18 percent above the USD 305.31 US quote.

Comparison with peers

Cigna Group: 1.63 percent higher versus the Xetra close, P/E 12.62, market capitalization USD 80.7 billion.

Elevance Health (NYSE, USD): up 1.55 percent on October 20, 2026, P/E 19.42, market capitalization USD 94.8 billion.

Humana (NYSE, USD): up 2.54 percent on October 20, 2026, P/E 40.22, market capitalization USD 51.1 billion.

What comes before the report?

The next dated catalyst is the November 5, 2026 release, followed by the 8:30 a.m. ET conference call. Until then, the contrast between Cigna's USD 71.67 billion quarterly revenue and its 12.62 P/E ratio remains central to the stock's valuation discussion.

Euro quote and investor frame

The Xetra close of October 19, 2026 was EUR 266.45. At Lang & Schwarz, Cigna Group stock was trading at EUR 270.80 on October 20, 2026 at 4:31 p.m. CEST, 1.63 percent above that close. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.